Cargando…
Advances in treating acute myeloid leukemia
Acute myeloid leukemia (AML) arises within the bone marrow from a malignant hematopoietic progenitor cell. Though AML is still often fatal, cure rates overall continue to improve incrementally yet steadily, primarily for two reasons: first, insights into the pathogenesis of AML over the last several...
Autores principales: | Showel, Margaret M., Levis, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191225/ https://www.ncbi.nlm.nih.gov/pubmed/25374674 http://dx.doi.org/10.12703/P6-96 |
Ejemplares similares
-
Potential targeting of FLT3 acute myeloid leukemia
por: Ambinder, Alexander J., et al.
Publicado: (2020) -
The clinical impact of the molecular landscape of acute myeloid leukemia
por: Kayser, Sabine, et al.
Publicado: (2023) -
Advances in targeted therapy for acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020) -
Health-Related Quality of Life of Patients with Acute Myeloid Leukemia: A Systematic Literature Review
por: Korol, Ellen E., et al.
Publicado: (2017) -
Recent advances in the treatment of acute myeloid leukemia
por: Abdel-Wahab, Omar, et al.
Publicado: (2010)